Skip to main content

electroCore, Inc.

ECOR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001560258

In the last 90 days, electroCore, Inc. insiders filed 3 open-market purchases and 1 sale; 32 institutions reported holding it in 13F filings for Q2 2026, worth $8.86M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding electroCore, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ECOR: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders40239+1
Shares12.6M142.6K12.2M−265.8K (−2.1%)
Value$5.13M$58.0K$3.14M−$1.93M (−38.1%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held electroCore, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ECOR in Q4 2022
InstitutionSharesValue% of portfolio
International Assets Investment Management, LLC349,575$89.7K0.01%
Citadel Advisors LLC100,446$25.8K0.00%
Susquehanna International Group, LLP21,068$5.41K0.00%
Perigon Wealth Management, LLC11,000$2.82K0.00%
The PNC Financial Services Group, Inc.200$520.00%
Royal Bank of Canada14$00.00%

Sold out (5)

Institutions that held electroCore, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ECOR in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Gabelli Funds LLC102,000$41.0K
UBS Group AG72,134$29.0K
Brown Brothers Harriman & Co20,000$8.00K
HRT Financial LP13,761$5.00K
Atlas Capital Advisors LLC2,000$812

Not filed for Q4 2022 yet (2)

Institutions that held electroCore, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ECOR in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Eidelman Virant Capital85,000$35.0K
SWM Advisors57,639$23.0K